HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less treatment be enough for HPV throat cancer?
Disease control OngoingThis study is testing whether a lower dose of chemotherapy and radiation after robotic surgery works as well as standard treatment for HPV-positive throat cancer, but with fewer side effects. It will include 40 patients who have had surgery to remove their cancer. The main goal i…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Custom immune cells unleashed against multiple cancers in pioneering trial
Disease control OngoingThis early-stage study is testing the safety of a new, personalized cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors collect a patient's own immune cells, genetically modify them to better recognize and attack their s…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New cancer vaccine combo aims to outperform standard treatment in major trial
Disease control OngoingThis large, late-stage trial is testing whether adding an experimental immunotherapy called PDS0101 to the standard drug pembrolizumab (Keytruda) helps people with advanced HPV-positive head and neck cancer live longer. The study will enroll about 351 adults whose cancer has retu…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Could a simple blood test spot throat cancer early?
Diagnosis OngoingThis study is testing whether a blood test can help find HPV-related throat cancer early. Researchers are enrolling adults aged 45+ with certain sexual histories who have not had this cancer before. The goal is to see if looking for traces of HPV in the blood is a practical way t…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Mar 27, 2026 12:37 UTC
-
Major trial tests if HPV vaccine can block oral cancer risk in HIV-Positive men
Prevention OngoingThis study is testing whether the 9-valent HPV vaccine can prevent persistent oral HPV infections in men living with HIV. It involves 700 adult men who will receive either the real vaccine or a placebo over several months. Researchers will track whether the vaccine reduces new, l…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Weill Medical College of Cornell University • Aim: Prevention
Last updated Mar 31, 2026 12:12 UTC